HOFT:NASDAQHooker Furnishings Corporation Analysis
Data as of 2026-05-19 - not real-time
$13.10
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Hooker Furnishings is trading above its short‑term and long‑term moving averages, with the price sitting just below a key resistance level and comfortably above the identified support zone. The RSI sits in the neutral zone while the MACD histogram has turned positive, suggesting a modest bullish bias, yet the volume trend is weakening and the 30‑day volatility remains elevated, flagging potential price swings. The stock’s beta is low, indicating limited correlation with broader market moves, but the recent decline in trading activity points to liquidity constraints that could amplify short‑term price moves. Fundamentally, the company posted a steep revenue decline and is currently generating negative margins, though cash flow from operations remains positive. Forward earnings estimates have turned positive and the forward P/E is in a reasonable range, while the price‑to‑book and price‑to‑sales multiples are well below industry averages, hinting at a valuation gap. The dividend yield is attractive and the payout ratio is extremely low, implying that the dividend is likely sustainable despite the earnings shortfall. However, the balance sheet shows a high debt load relative to equity and cash reserves are modest, which could pressure the company if earnings do not improve. Given the combination of a potential valuation upside, a sustainable dividend, and significant operational risks, the stock sits at a crossroads between value appeal and earnings uncertainty.
Overall, the technical picture is cautiously optimistic but tempered by low liquidity and high volatility, while the fundamentals suggest a turnaround is needed to validate the current price level. Investors should weigh the attractive dividend and low valuation against the earnings deficits, heavy debt, and sector cyclicality before deciding on positioning.
Overall, the technical picture is cautiously optimistic but tempered by low liquidity and high volatility, while the fundamentals suggest a turnaround is needed to validate the current price level. Investors should weigh the attractive dividend and low valuation against the earnings deficits, heavy debt, and sector cyclicality before deciding on positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price hovering just below resistance with limited upside on the near term
- decreasing volume and elevated volatility increase short‑term price uncertainty
- technical indicators show a modest bullish bias but lack strong momentum
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- forward earnings are projected to turn positive, supporting a higher valuation
- valuation multiples (price‑to‑book and price‑to‑sales) are well below peers
- high dividend yield with a very low payout ratio suggests sustainable income
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- persistent negative margins and a sizable debt burden pose structural challenges
- sector cyclicality could amplify earnings volatility over longer horizons
- valuation upside remains attractive if the company can achieve an earnings turnaround
Key Metrics & Analysis
Financial Health
Revenue Growth-20.50%
Profit Margin-9.70%
P/E Ratio10.2
ROE-6.84%
ROA-0.25%
Debt/Equity16.63
P/B Ratio0.8
Op. Cash Flow$20.2M
Free Cash Flow$35.4M
Technical Analysis
TrendNeutral
RSI54.2
Support$11.75
Resistance$13.58
MA 20$12.62
MA 50$12.81
MA 200$11.55
MACDBullish
VolumeDecreasing
Fear & Greed Index89.04
Valuation
Fair Value$40.09
Target Price$15.00
Upside/Downside14.50%
GradeUndervalued
TypeValue
Dividend Yield3.52%
Risk Assessment
Beta0.50
Volatility61.01%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.